longevity research

1 statements across 1 episodes · 0 bullish · 0 bearish · 1 people on the record · first statement Sep 13, 2017 by Elizabeth Iorns · across every show →

Everything said about longevity research, oldest first

Sep 13, 2017 neutral
Insight
Iorns: Human longevity trials are impractical without secondary biomarker endpoints
“If you do that invention, you do that intervention in humans, you're going to have to wait A really long time to know whether it actually worked, and so that clinical study is very difficult if you don't have a secondary endpoint that you can measure.”
Elizabeth Iorns Sep 13, 2017 ▶ 32:33 Elizabeth Iorns on Biotech Companies in YC · Y Combinator
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 300 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.